Delphyr
Category: AI in Healthcare
Delphyr is a Netherlands-based AI platform developing AI agents for healthcare that integrate into existing EHR systems to reduce administrative burden on clinicians through search, summarization, ambient listening, and workflow automation. Delphyr was founded in 2023. The company is led by Michel Abdel Malek. Based in Amsterdam, Netherlands. Team size: 11-50. Total funding raised: $2.2M. Latest round: Seed. Key investors include Innovatiefonds Noord-Holland, Thomas Wolf (co-founder of Hugging Face), Founders of DEGIRO.
- Founded
- 2023
- Headquarters
- Amsterdam, Netherlands
- Team size
- 11-50
- Total funding
- $2.2M
Value proposition
An intelligence layer that works alongside existing healthcare IT systems (not replacing them), reducing clinicians' administrative burden by up to 90% while maintaining EU data sovereignty, GDPR compliance, and MDR certification standards.
Products and solutions
Delphyr Clinical Co-Pilot — AI platform integrating into existing EHRs (Bricks/Tetra, ChipSoft HiX) offering: (1) Search & Summarize — instant retrieval and condensation of patient data from notes, labs, imaging, medications, and correspondence, (2) Evidence-Based Guidance — access to clinical guidelines and vetted medical sources, (3) Ambient Listening — capture consultations and auto-convert speech to structured clinical notes, (4) Workflow Automation — generate patient summaries, draft consultation notes, prepare correspondence and e-consults.
Unique value
Purpose-built for European healthcare with EU data sovereignty (all data processed within Europe), compliance with EU AI Act and MDR, integration with Dutch EHRs (Bricks/Tetra, ChipSoft HiX) without workflow disruption, and a proprietary 7B-parameter Dutch clinical LLM (M1) that outperforms LLaMA3 on medical benchmarks (PubMedQA 76.8%).
Target customer
Hospitals, primary care practices, and mental healthcare settings in the Netherlands and Europe
Industries served
Healthcare (hospitals, primary care, mental health)
Technology advantage
Proprietary M1 model — a 7B-parameter Dutch clinical LLM fine-tuned in-house, outperforming LLaMA3 on PubMedQA (76.8%). Integrates zero-disruption into existing EHRs (Bricks/Tetra, ChipSoft HiX). Runs on secure European infrastructure (Microsoft Azure ecosystem). End-to-end monitoring for compliance. Regulated as a medical device (MDR certification in progress).
How they differentiate
Unlike US-focused ambient scribes (e.g., Abridge, Nabla), Delphyr focuses on the 90% of clinician cognitive load that occurs before and after consultations (not just the 10% during patient conversations). It is built by a practicing anesthesiologist, processes all data on European infrastructure, complies with EU AI Act/MDR/GDPR, integrates with Dutch-specific EHRs (Bricks, ChipSoft), and emphasizes verifiable outputs with citations for clinician trust.
Main competitors
Abridge (US, ambient scribe, $300M+ raised), Nabla (US/France, ambient AI scribe), Tandem Health (Stockholm, AI clinical documentation, €42.6M Series A), voize (Berlin, AI clinical documentation, €43M Series A)
Key partnerships
InterSystems (data infrastructure partnership for scalable deployment), Bricks by Tetra (EHR integration), ChipSoft HiX (EHR integration), Microsoft Azure (cloud infrastructure), Erasmus MC (ICU pilot), Dutch Endometriosis Clinic (hospital pilot)
Notable customers
Mental health hospital in the Netherlands (live deployment), Erasmus MC (ICU pilot), Dutch Endometriosis Clinic (pilot), Primary care practices using Bricks EHR
Major milestones
2023: Company founded, 2024: €275K convertible loan from Innovatiefonds Noord-Holland, 2025: STZ Innovation Challenge win, Jan 2026: Live in Bricks EHR for primary care, Mar 2026: €1.75M Seed round led by Innovatiefonds Noord-Holland with backing from Hugging Face and DEGIRO founders, 2026: Pilots with Erasmus MC ICU and Dutch Endometriosis Clinic, MDR certification in progress
Growth metrics
Growing from 7 to 13-15 employees post-Seed round; deployed in one mental health hospital with several more deployments in pipeline; revenue starting to come in alongside investment
Market positioning
Early-stage European healthcare AI startup focused on the Dutch market, positioned as a privacy-compliant, EU-sovereign alternative to US-based ambient scribe and clinical AI platforms. Targeting the €56B global AI healthcare market projected to reach $1T+ by 2034.
Geographic focus
Netherlands (primary), expanding across Europe
About Michel Abdel Malek
Ex-Anesthesiologist; MD; PhD candidate in generative AI for anesthesia at Leiden UMC. Peer reviewer for BMJ Digital Health and British Journal of Anaesthesia. TEDx speaker. Built Delphyr after a near-miss clinical error caused by fragmented patient data.
Latest news about Delphyr
More AI in Healthcare companies
Official website: https://www.delphyr.ai